Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Loh

Showing results (381-390 of 479) with videos related to

Pageof 48
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2021
Favorable Trisomies and <i>ETV6-RUNX1</i> Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331Leonard A Mattano, Meenakshi Devidas, Kelly W Maloney, et al.
Haematologica|June 13, 2024
Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed <i>KMT2A</i>-rearranged acute lymphoblastic leukemia: Children's Oncology Group trial AALL15P1Erin M Guest, John A Kairalla, Meenakshi Devidas, et al.
Nature Communications|February 6, 2024
Smith-specific regulatory T cells halt the progression of lupus nephritisPeter J Eggenhuizen, Rachel M Y Cheong, Cecilia Lo, et al.
Blood Advances|March 7, 2018
Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemiaThai Hoa Tran, Marian H Harris, Jonathan V Nguyen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2016
Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemiaKoichi Oshima, Hossein Khiabanian, Ana C da Silva-Almeida, et al.
Blood|June 4, 2017
Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMMLAkihide Yoshimi, Maria E Balasis, Alexis Vedder, et al.
Nature|March 25, 2015
Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemiaZhengshan Chen, Seyedmehdi Shojaee, Maike Buchner, et al.
Blood|January 10, 2025
DNTT-mediated DNA damage response drives inotuzumab ozogamicin resistance in B-cell acute lymphoblastic leukemiaCarolin S Escherich, Takaya Moriyama, Zhenhua Li, et al.
Leukemia|March 11, 2021
Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working GroupShinsuke Hirabayashi, Ellie R Butler, Kentaro Ohki, et al.
The Lancet. Haematology|December 28, 2020
Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort studyMonique L den Boer, Gunnar Cario, Anthony V Moorman, et al.
Pageof 48

Showing results (381-390 of 479) with videos related to

Sort By:
Pageof 48
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2021
Favorable Trisomies and <i>ETV6-RUNX1</i> Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331Leonard A Mattano, Meenakshi Devidas, Kelly W Maloney, et al.
Haematologica|June 13, 2024
Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed <i>KMT2A</i>-rearranged acute lymphoblastic leukemia: Children's Oncology Group trial AALL15P1Erin M Guest, John A Kairalla, Meenakshi Devidas, et al.
Nature Communications|February 6, 2024
Smith-specific regulatory T cells halt the progression of lupus nephritisPeter J Eggenhuizen, Rachel M Y Cheong, Cecilia Lo, et al.
Blood Advances|March 7, 2018
Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemiaThai Hoa Tran, Marian H Harris, Jonathan V Nguyen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2016
Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemiaKoichi Oshima, Hossein Khiabanian, Ana C da Silva-Almeida, et al.
Blood|June 4, 2017
Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMMLAkihide Yoshimi, Maria E Balasis, Alexis Vedder, et al.
Nature|March 25, 2015
Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemiaZhengshan Chen, Seyedmehdi Shojaee, Maike Buchner, et al.
Blood|January 10, 2025
DNTT-mediated DNA damage response drives inotuzumab ozogamicin resistance in B-cell acute lymphoblastic leukemiaCarolin S Escherich, Takaya Moriyama, Zhenhua Li, et al.
Leukemia|March 11, 2021
Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working GroupShinsuke Hirabayashi, Ellie R Butler, Kentaro Ohki, et al.
The Lancet. Haematology|December 28, 2020
Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort studyMonique L den Boer, Gunnar Cario, Anthony V Moorman, et al.
Pageof 48